Molecular Partners (MOLN) Short Interest Ratio & Short Volume → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free MOLN Stock Alerts Notice: Trading of Molecular Partners halted at 09:56 AM EST due to "LULD pause". $3.70 -0.06 (-1.60%) (As of 05/9/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media Molecular Partners Short Interest DataCurrent Short Volume56,400 sharesPrevious Short Volume47,900 sharesChange Vs. Previous Month+17.75%Dollar Volume Sold Short$222,780.00Short Interest Ratio / Days to Cover18.8Last Record DateApril 15, 2024Outstanding Shares36,369,000 sharesPercentage of Shares Shorted0.16%Today's Trading Volume3,086 sharesAverage Trading Volume12,668 sharesToday's Volume Vs. Average24% Short Selling Molecular Partners ? Sign up to receive the latest short interest report for Molecular Partners and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMOLN Short Interest Over TimeMOLN Days to Cover Over TimeMOLN Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Molecular Partners Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202456,400 shares $222,780.00 +17.8%N/A18.8 $3.95 3/31/202447,900 shares $201,180.00 -2.2%N/A9.8 $4.20 3/15/202449,000 shares $194,040.00 -12.5%N/A3.7 $3.96 2/29/202456,000 shares $240,800.00 -7.6%N/A4.1 $4.30 2/15/202460,600 shares $282,093.00 +3.6%N/A4.5 $4.66 1/31/202458,500 shares $279,630.00 -13.7%N/A4.4 $4.78 Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 1/15/202467,800 shares $323,406.00 +1,132.7%N/A4.9 $4.77 12/31/20235,500 shares $22,989.45 -11.3%N/A0.4 $4.18 12/15/20236,200 shares $26,102.00 -39.2%N/A2.4 $4.21 11/30/202310,200 shares $42,840.00 +117.0%N/A2.6 $4.20 11/15/20234,700 shares $20,774.00 -4.1%N/A1 $4.42 10/31/20234,900 shares $17,297.00 +2.1%N/A0.9 $3.53 10/15/20234,800 shares $20,884.32 -34.3%N/A1 $4.35 9/30/20237,300 shares $30,222.00 -73.1%N/A1.6 $4.14 9/15/202327,100 shares $123,576.00 +173.7%N/A6 $4.56 8/31/20239,900 shares $59,301.00 +135.7%N/A3.5 $5.99 8/15/20234,200 shares $24,822.00 +23.5%N/A2.1 $5.91 7/31/20233,400 shares $20,349.00 +21.4%N/A2.6 $5.99 7/15/20232,800 shares $18,312.00 -46.2%N/A2.3 $6.54 6/30/20235,200 shares $32,344.00 -3.7%N/A4 $6.22 6/15/20235,400 shares $35,748.00 +54.3%N/A4.2 $6.62 5/31/20233,500 shares $22,470.00 -31.4%N/A2.1 $6.42 5/15/20235,100 shares $33,762.51 -42.7%N/A3.6 $6.62 4/30/20238,900 shares $58,651.00 -60.4%N/A4.9 $6.59 4/15/202322,500 shares $146,925.00 +9.2%N/A10.2 $6.53 3/31/202320,600 shares $124,380.74 +32.1%N/A9.4 $6.04 3/15/202315,600 shares $91,416.00 +2.6%N/A6.2 $5.86 2/28/202315,200 shares $95,000.00 No ChangeN/A4.8 $6.25 2/15/202315,200 shares $97,584.00 -2.6%N/A4.5 $6.42 1/31/202315,600 shares $100,620.00 -1.3%N/A3 $6.45 1/15/202315,800 shares $107,484.24 +22.5%N/A2.8 $6.80 12/30/202212,900 shares $84,495.00 +10.3%N/A1.7 $6.55 12/15/202211,700 shares $80,028.00 -14.0%N/A1.4 $6.84 11/30/202213,600 shares $87,040.00 +9.7%N/A1.5 $6.40 11/15/202212,400 shares $86,056.00 -2.4%N/A1.3 $6.94 10/31/202212,700 shares $79,122.27 -7.3%N/A1.3 $6.23 10/15/202213,700 shares $83,433.00 -12.7%N/A1.5 $6.09 9/30/202215,700 shares $105,033.00 -20.7%N/A1.7 $6.69 9/15/202219,800 shares $124,938.00 -26.4%N/A1.9 $6.31 8/31/202226,900 shares $157,634.00 -9.4%N/A2 $5.86The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. MOLN Short Interest - Frequently Asked Questions What is Molecular Partners' current short interest? Short interest is the volume of Molecular Partners shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 56,400 shares of MOLN short. Learn More on Molecular Partners' current short interest. What is a good short interest ratio for Molecular Partners? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MOLN shares currently have a short interest ratio of 19.0. Learn More on Molecular Partners's short interest ratio. Is Molecular Partners' short interest increasing or decreasing? Molecular Partners saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 56,400 shares, an increase of 17.7% from the previous total of 47,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Molecular Partners' short interest compare to its competitors? Here is how the short interest of companies compare to Molecular Partners: Vaxart, Inc. (10.37%), Cardiol Therapeutics Inc. (0.42%), DBV Technologies S.A. (0.27%), Karyopharm Therapeutics Inc. (20.23%), Scilex Holding (7.13%), Vigil Neuroscience, Inc. (6.18%), Omega Therapeutics, Inc. (21.69%), Cardiff Oncology, Inc. (8.92%), aTyr Pharma, Inc. (0.56%), BioAtla, Inc. (11.27%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Molecular Partners stock? Short selling MOLN is an investing strategy that aims to generate trading profit from Molecular Partners as its price is falling. MOLN shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Molecular Partners? A short squeeze for Molecular Partners occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MOLN, which in turn drives the price of the stock up even further. How often is Molecular Partners' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MOLN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Vaxart Short Squeeze Cardiol Therapeutics Short Squeeze DBV Technologies Short Squeeze Karyopharm Therapeutics Short Squeeze Scilex Short Squeeze Vigil Neuroscience Short Squeeze Omega Therapeutics Short Squeeze Cardiff Oncology Short Squeeze aTyr Pharma Short Squeeze BioAtla Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MOLN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetry348 million Americans lives to END as we know it?The Oxford Club